CARE reaffirms ratings of Suven Life Sciences’ bank facilities

21 Dec 2013 Evaluate

Credit rating agency, CARE has reaffirmed ‘BBB-’ rating to Suven Life Sciences’ long term bank facilities worth Rs 138.11 crore which was enhanced from Rs 105.56 crore and ‘A3’ rating to company’s Short term Bank Facilities worth Rs 22.50 crore which was enhanced from Rs 16.50 crore.

The company has received the said rating on the back of its experienced promoter and management team, established track record under CRAMS with reputed clientele, strong Research & Development (R&D) competency, growing scale of operations with improving profitability margins and satisfactory gearing levels over the period.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.

Suven Life Sciences Share Price

144.00 7.95 (5.84%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×